Ir para o conteúdo principal

United States Technology

Grafa
Health

Danaher tops forecasts as bioprocessing recovery fuels 2026 growth outlook

Danaher (NYSE:DHR) reported fourth-quarter results that surpassed Wall Street estimates on Wednesday, providing a bullish outlook for 2026 that suggests the long-awaited recovery in the bioprocessing and life sciences sectors is finally taking hold.

Leia mais: Danaher tops forecasts as bioprocessing recovery fuels 2026 growth outlook